Merck, Schering-Plough to develop ezetimibe-atorvastatin

MRK and SGP will develop a fixed-dose combination

Read the full 80 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE